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Somatic Cells as Indicators of Germinal
Mutations in the Mouse
by Liane B. Russell*
In attempts to find a prescreen for mutagens that may induce heritable mutations in mammals, an in
vivo somatic mutation test has been developed in the mouse that uses a localized gene product (hair
pigment), is relatively fast and cheap, and gives results that have some predictive value for point mutation
induction in spermatogonia. Embryos heterozygous at specific coat color loci are exposed to the presump-
tive mutagen, and 3 weeks later the fur is observed for spots of altered color. It is possible to distinguish
spots resulting from expression of the recessive (RS's) from spots having various other causes.
In tests with seven compounds, mutation rates per locus and unit dose have been calculated on the
assumption that 175 cells are at risk per 101/4-day embryo (a number derived from distribution of spot
proportions). These rates are found to be roughly parallel to, but uniformly higher than spermatogonial
point-mutation rates for the same seven compounds. The higher somatic rates are presumably due to the
fact that RS's can result from several genetic mechanisms besides point mutations. The spot test, which
has not to date given any false negatives, may thus be considered a useful in vivo prescreen for heritable
germinal mutations in mammals.
Despite the recent proliferation in development of
submammalian and in vitro test systems for
mutagenic studies, there is general agreement that
in vivo studies on heritable genetic effects in mam-
mals must, at some stage, enter into the risk evalu-
ation for compounds that show a potential for af-
fecting human populations. Since such testing can,
however, be relatively time- and space-consuming,
it must be reserved for only selected possible muta-
gens.
For this reason, some effort has been devoted to
the perfection of an in vivo mammalian somatic-
mutation test that might be capable of acting as a
prescreen for germinal mutations of various kinds.
This test was first developed by us in an x-ray ex-
periment about 20 years ago and, at that time,
explored for its various- complexities (1). The use-
fulness of the method in chemical mutagenesis has
been tested more recently (2-9). We have elsewhere
presented some of our recent results in some detail
(3), have discussed some of the more basic aspects
of the method (9), and have compared the interpre-
tations various investigators have made oftheirdata
(9). For the purposes of this symposium, some of
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the findings will be summarized, and the relation
between somatic and germinal mutation rates
explored.
In a germinal mutation experiment, each indi-
vidual examined for presence or absence of a
whole-body mutation scores one cell that was at
risk to the mutagen. In an in vivo somatic mutation
experiment, an individual is examined, instead, for
clones of mutant cells (Fig. 1). While each clone
again representsjust one cell at risk, the whole irndi-
vidual represents a population of cells at risk-an
obvious advantage in numbers. It should be noted,
however, that the altered clone (consisting, as it
does, ofsomatic cells) cannot ordinarily be involved
in breeding tests, so that the nature of the genetic
event that produced it cannot be genetically
analyzed.
The method as originally developed (1) meets the
following prerequisites of a successful somatic mu-
tation prescreen: it uses a localized gene product
(namely hair pigment) so that clones ofexceptional
cells can be directly identified; it involves an in vivo
mammalian situation; and it is relatively fast and
cheap. In addition, as more recently demonstrated,
the results have predictive value for germinal point
mutations (3, 9).
The in vivo somatic mutation test consists of
treating embryos (i.e., populations ofcells) that are
June 1978 113FIGURE 1. Schematic representation of mutations induced in a
germ cell (left portion offigure), and in a somatic cell during
embryonic development (right portion). The treatment stage
is indicated by a wavy arrow, and the animals observed by
the balls of cells at the bottom of the figure.
heterozygous at specific coat color loci, allowing
animals to be born and to grow a coat, and examin-
ing this for mosaic patches, indicative of clones of
mutant cells. From the time ofmating the animals to
the final result, this process takes only 5 weeks.
Recessive mutations at the heterozygous loci do
not, however, constitute the only cause of spots.
This feature ofthe results, ifproperly used, can lend
additional resolving power to the method. It can,
however, also lead to misinterpretation in inexperi-
enced hands. Our interpretation of the various
causes of spots was derived from a comparison of
results from heterozygous embryos with those from
homozygous wild-type embryos (having mothers of
the same strain): types of spots found exclusively in
the former population are presumably due to an
"'uncovering" of the recessive, while types of spots
found in both populations presumably have other
causes (1). The various causes of spots are sum-
marized in Table 1.
In order to determine whether there was any re-
lation between the frequency of recessive spots
(RS) and the frequency ofgerminal point mutations,
we carried out in vivo somatic-mutation tests with
compounds for which specific-locus mutation-rate
data are available for spermatogonia. [Sper-
matogonia are the male cell stage of importance for
risk evaluations (1O).] These results, an extension of
some published earlier (3), are summarized in Table
2. White near-midline ventral spots (WMVS), which
are scored independently of RS's, are found with
elevated frequencies in some of the treatment
groups, generally those yielding also appreciable
frequencies of malformed animals (observed by
external examination at birth). Both WMVS's and
teratogenic effects have been ascribed to cell killing
(3).
Doses that have been used in spermatogonial
specific-locus experiments are generally near the
highest compatible with continuous fertility of the
males. In the spot test, however, the maximum tol-
erated doses are considerably lower, since the
method requires the treatment of embryos during
one of their most vulnerable stages, day 10¼/4 (1). In
general, we have found it possible to use arrays of
exposures that straddle a dose one-third of the one
used in spermatogonia. In such dose ranges, one
Table 1. Causes and appearance of spots found in the in vivo somatic-mutation test.
Cause of spot Color' Location Symbol
Expression of the recessive at marked loci RS
Somatic point mutation to the recessive Various shades of gray,
brown, or tan
Deficiency of a chromosomal segment Random
Various shades of gray,
Whole chromosome loss (from nondisjunction brown, or tan; or
or other causes) near-white
Somatic recombination
Other events
Decrease in melanocyte precursor cells White Near midline, WMVS
ventral
Errors in differentiation Near-agouti (yellowish- Nipple sites, DS
brown) genitals, snout,
base of ears;
forehead tufts.
Dominant mutations scattered through Various shades of gray,
genomeb brown, tan, cream,
yellow; white
a Colors listed are for the case in which ala; +Ib; + +/cchp; + +Id se; +Is embryos are treated.
b Probably rare.
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jTable 2. Spot incidence and morphology in offspring of a cross of obtains near-normal litter sizes and survival to 12
C57BL females by T males, following injection with various agents days (3), the age for initial scoring for spots.
on day 10'/4 postconception. Since it is not possible to compare the sper-
Abnormal matogonial and somatic mutation results at the
morphology same dose points, mutation rates per unit dose have
Dose, No. at birth, WMVS, RS, been computed for both sets of data. The induced
Agent"~ mg/kg born %b %b spermatogonial mutation rate was calculated for
EMS 50 93 0 3.7 (1.2)? seven loci from data of Russell, Ehling, and Cat- 100 193 1.6 2.5 0.6 tanach (3) and from unpublished BP and DEN data
MMS 50 126 0.8 1.7 0.9 of W. L. Russell, subtracting the overall control 100 69 16.4 13.1 4.9 rate (11) of 28 in 531,500. To calculate mutation
TEM 0.5 149 47.7 17.5 3.3 rates for the spot-test results, one must first esti- 0.8 126 91.1 22.0 2.4 mate the number of precursor cells at risk at the
MC 2 91 5.5 15.2 3.0 time of treatment. A distribution was derived by
BP 100 171 0.7? 4.9 2.1 estimating, for each spot induced on day 101/4, the
150 135 0.9 3.6 4.5 proportion of total fur occupied, and assuming that
20 57 0 8.9 (1.8)? the reciprocal of this proportion represents the
HC 30 228 0.4 13.5 0.5 number of precursor cells (1). Since the mode lies
50 160 16.3 8.1 1.5 *0 160 16.3 8. i 1.5 between 150 and 200, we have used a figure of 175
20 79 0 2.9 0 for the cell population at risk per embryo. The
DEN 30 148 0 2.9 1.6 number of loci screened in the spot test was proba-
Control - 1562 0 3.8 0 bly four (9). Control 562 0 3.8 0 The mutation rates per locus per unit dose for
(I Abbreviations: EMS, ethyl methanesulfonate; MMS, methyl both sets of data are listed in Table 3. The induced
methanesulfonate, TEM, triethylenemelamine; MC, mitomycin spermatogonial rate is shown on line with the
C: HC, hycanthone; BP, benzo[a]pyrene; DEN, diethylnit- somatic rate per unit dose is, in each case, consid- rosamine.
b See Table 1, last column, for explanation of symbols. erably higher than the spermatogonial rate (and
somatic rate per unit dose is, in each case consid-
erably higher than the spermatogonial rate (and
Table 3. Comparison of mutation rates at specific loci induced by higher even than the upper 95% confidence limit in
seven agents in spermatogonia or somatic cells. cases where the spermatogonial rate was zero).
The relatively higher RS frequencies, and the fact
Spermatogonia Melanocyte precursors that easily measurable, though low, RS rates are
Dose Mutation rateb Dose, Mutation rateb obtained for compounds that have yielded totally
Agent" mg/kg x 10-7 mg/kg x 10-' negative results in germinal (spermatogonial) ex-
EMS 50 (0, or 3.5'?) periments, is undoubtedly due to the fact that ex-
293.1 0 (U95%CL, 0.8)" 100 0.9 pression of the recessive, which is scored in the
MMS 101.3c 0.8 spot-test, can be brought about by several
50 2.5 mechanisms besides point mutations (Table 1).
100 (7.0) There is evidence from certain known chromosome
TEM 0.5 952.4 aberrations that relatively long autosomal deficien-
2.3w 128.8 0.8 (435.5) cies are tolerated if they occur in up to about one-
MC 5.25 64.5 2.0 (216.5) half the somatic cells of a mouse (12). It is conceiv-
HC 30 2.3 able that even monosomies could survive in a small
150 0 (U95S%CL, 2.2)" 50 3.9 clone. By contrast, almost all spermatogonially in-
BP 100 3.0 duced mutations are either intragenic changes or
500 0 150 4.3 minute deficiencies (13).
DEN 20 (0) For these reasons, results from the in vivo
30 7.2 somatic-mutation test-even if carefully restricted
138' 0 50 5.0 to true RS's-can, and do, yield positive results for
a For abbreviations, see Table 2. compounds that are negative in spermatogonial
b Per locus (7 in spermatogonial, 4 in somatic cells), and per specific-locus tests, i.e., they give false positives in
unit dose. Rates based on fewer than 100 observations are shown a prescreen for germinal point mutations. Some of
in parentheses.
Weighted average these positives are probably the result of genetic
d Where no mutations were observed, the upper 95% confi- changes, other than point mutations, that represent
dence limits of zero-frequency is shown in parentheses. certain types of hereditary risks. The spot test has
I
June 1978 115not, to date, given any false negatives. Because of
this, and because of the finding of a rough paral-
lelism (i.e., a relatively higher frequency of RS's in
the case of compounds that induce spermatogonial
mutations), the spot test can be a useful in vivo
prescreen for heritable germinal mutations in
mammals.
This research was sponsored by the Energy Research and De-
velopment Administration under contract with the Union Car-
bide Corporation.
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